A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity
Clinical trial NCT01262664 · TERMINATED
Trial details
- NCT number
- NCT01262664
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-24
- Primary completion
- 2019-01-02
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.